Study of ESG406 in Adults With Solid Tumors

Clinical trial NCT06979674 · RECRUITING

Trial details

NCT number: NCT06979674
Sponsor: Shanghai Escugen Biotechnology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced/Metastatic Solid Tumors

Start date: 2025-06-04
Primary completion: 2028-04-01
Enrollment: 556

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.